AGP Executive Report
Last update: 2 hours agoNewborn Vaccine Trial Halted: Guinea-Bissau has cancelled a proposed U.S.-funded hepatitis B study involving 14,000 babies. The plan would have delayed vaccination for half the infants until six weeks of age, despite the WHO recommending a dose at birth. Health experts warned the delay could leave newborns exposed to infection. The health minister said the government had not approved the trial, and police seized vaccine supplies from the research centre as authorities examined whether the project met national safety and ethics rules.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.